Literature DB >> 17513429

Aromatic amino acid requirements in healthy human subjects.

Paul B Pencharz1, Jean W-C Hsu, Ronald O Ball.   

Abstract

Dietary aromatic amino acids are needed to meet the requirements for phenylalanine and tyrosine for protein synthesis. The amounts needed for neurotransmitter synthesis and other biological processes are small and quantitatively negligible. The earlier nitrogen balance-based estimates were judged to be inadequate. Very recently, there have been 3 estimates published based on the indicator amino acid oxidation technique, which average 42 mg.kg(-1).d(-1). This average value was obtained by feeding subjects a tyrosine-free diet and hence is an estimate of the mean maximum phenylalanine requirement. The mean minimum phenylalanine requirement estimate in the presence of an excess of tyrosine is 9.1 mg.kg(-1).d(-1). Hence, tyrosine can spare 78% of the dietary phenylalanine need. Finally the optimal proportions of dietary phenylalanine and tyrosine have been shown to be 60:40, respectively.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17513429     DOI: 10.1093/jn/137.6.1576S

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  6 in total

1.  The Phenylalanine Requirement of Elderly Men and Women Measured by Direct 13C Carbon Oxidation Method Is Similar to That of Young Adults.

Authors:  Kimberly E Martin; Paul B Pencharz; Mahroukh Rafii; Ronald O Ball; Sylwia Szwiega; Rajavel Elango; Glenda Courtney-Martin
Journal:  J Nutr       Date:  2019-10-01       Impact factor: 4.798

2.  Dietary phenylalanine requirements during early and late gestation in healthy pregnant women.

Authors:  Madeleine A Ennis; Betina F Rasmussen; Kenneth Lim; Ronald O Ball; Paul B Pencharz; Glenda Courtney-Martin; Rajavel Elango
Journal:  Am J Clin Nutr       Date:  2020-02-01       Impact factor: 7.045

3.  Comparing the Phenylalanine/Tyrosine Pathway and Related Factors between Keratopathy and No-Keratopathy Groups as Well as between Genders in Alkaptonuria during Nitisinone Treatment.

Authors:  Lakshminarayan R Ranganath; Anna M Milan; Andrew T Hughes; Andrew S Davison; Milad Khedr; Richard Imrich; Mattias Rudebeck; Birgitta Olsson; Brendan P Norman; George Bou-Gharios; James A Gallagher
Journal:  Metabolites       Date:  2022-08-22

4.  Determinants of tyrosinaemia during nitisinone therapy in alkaptonuria.

Authors:  L R Ranganath; A M Milan; A T Hughes; A S Davison; Khedr M; B P Norman; G Bou-Gharios; J A Gallagher; R Imrich; J B Arnoux; M Rudebeck; B Olsson
Journal:  Sci Rep       Date:  2022-09-27       Impact factor: 4.996

5.  The Association of Aromatic Amino Acids with Incident Hip Fracture, aBMD, and Body Composition from the Cardiovascular Health Study.

Authors:  Brian Le; Petra Bůžková; John A Robbins; Howard A Fink; Mattie Raiford; Carlos M Isales; James M Shikany; Steven S Coughlin; Laura D Carbone
Journal:  Calcif Tissue Int       Date:  2019-05-21       Impact factor: 4.333

6.  The Effect of Various Doses of Phenylalanine Supplementation on Blood Phenylalanine and Tyrosine Concentrations in Tyrosinemia Type 1 Patients.

Authors:  Willem G van Ginkel; Hannah E van Reemst; Nienke S Kienstra; Anne Daly; Iris L Rodenburg; Anita MacDonald; Johannes G M Burgerhof; Pim de Blaauw; Jennifer van de Krogt; Saikat Santra; M Rebecca Heiner-Fokkema; Francjan J van Spronsen
Journal:  Nutrients       Date:  2019-11-18       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.